Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.02M | 5.83M | 5.67M | 5.60M | 6.57M |
| Depreciation & Amortization | 43.00K | 51.00K | 54.00K | 41.00K | 27.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.76M | 16.09M | 18.25M | 18.97M | 19.69M |
| Operating Income | -11.76M | -16.09M | -18.25M | -18.97M | -19.69M |
| Income Before Tax | -76.81M | -81.52M | -85.93M | -170.42M | -126.85M |
| Income Tax Expenses | -9.49M | -10.40M | -10.55M | -25.50M | -13.80M |
| Earnings from Continuing Operations | -67.32 | -71.12 | -75.38 | -144.92 | -113.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 39.00K | 44.00K | 43.00K | 26.00K | 37.00K |
| Net Income | -67.28M | -71.08M | -75.34M | -144.90M | -113.01M |
| EBIT | -11.76M | -16.09M | -18.25M | -18.97M | -19.69M |
| EBITDA | -11.72M | -16.04M | -18.20M | -18.93M | -19.66M |
| EPS Basic | -64.27 | -68.81 | -73.92 | -159.24 | -130.34 |
| Normalized Basic EPS | -4.37 | -7.76 | -10.27 | -14.39 | -13.95 |
| EPS Diluted | -64.28 | -68.81 | -73.92 | -159.24 | -130.36 |
| Normalized Diluted EPS | -4.37 | -7.76 | -10.27 | -14.39 | -13.95 |
| Average Basic Shares Outstanding | 4.22M | 4.03M | 3.87M | 3.69M | 3.49M |
| Average Diluted Shares Outstanding | 4.22M | 4.03M | 3.87M | 3.69M | 3.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
